How Cancer Patients get Treated with our SPEAR T-Cells

SURPASS-2: investing ADP-A2M4CD8 SPEAR T-cell therapy to treat esophageal and GEJ cancersПодробнее

CAR-T cells versus SPEAR T-cells to treat solid tumorsПодробнее

AACR Annual Virtual Meeting 2021 - Focus on our SURPASS and ADP-A2AFP trialsПодробнее

Relapsed Therapy and Clinical Trials - Dr. Caitlin Costello: RCW San Diego 2021Подробнее

ITN Live - Update w/ Sonny BurksПодробнее

Adaptimmune reports updated SURPASS data at ESMO 2021Подробнее

SPEARHEAD-1: afamitresgene autoleucel in advanced synovial and myxoid liposarcomaПодробнее

Targeting solid tumors: SPEAR T-cells & HLA-independent TCRsПодробнее

why cannot immune system kill cancer!!!! cancer cells evade immune system... how?? (ANIMATED)Подробнее

Adaptimmune: SPEAR T-cellsПодробнее

Jonathan Silk: Next Generation approaches to enhance the efficacy of SPEAR T-cellsПодробнее

SPEAR T-cells Derived from Stem Cells Kill Cancer Targets in vitro - data from ASGCT 2020Подробнее

ASCO Data and Clinical Update: 29 May 2020Подробнее

Stem Cell and Gene Therapy - Matthew Porteus, Tippi Mackenzie, Matthew Spear, Stephen GottschalkПодробнее

SPEARHEAD-2 trial design: combining SPEAR T-cells with pembrolizumabПодробнее

How Our SPEAR T-cells WorkПодробнее

Adaptimmune SPEAR T-Cell Mechanism of Action VideoПодробнее

How the immune system fights ovarian cancer with Dr Sarah SpearПодробнее

CAR-T Cells: Poseida Therapeutics - Matt SpearПодробнее